These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23585908)

  • 1. Embryonic cardiomyocyte, but not autologous stem cell transplantation, restricts infarct expansion, enhances ventricular function, and improves long-term survival.
    Paulis LE; Klein AM; Ghanem A; Geelen T; Coolen BF; Breitbach M; Zimmermann K; Nicolay K; Fleischmann BK; Roell W; Strijkers GJ
    PLoS One; 2013; 8(4):e61510. PubMed ID: 23585908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Tongxinluo-facilitated cellular cardiomyoplasty with autologous bone marrow-mesenchymal stem cells on postinfarct swine hearts.
    Qian HY; Yang YJ; Huang J; Gao RL; Dou KF; Yang GS; Li JJ; Shen R; He ZX; Lu MJ; Zhao SH
    Chin Med J (Engl); 2007 Aug; 120(16):1416-25. PubMed ID: 17825171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-myocardial delivery of mesenchymal stem cells ameliorates left ventricular and cardiomyocyte contractile dysfunction following myocardial infarction.
    Li Q; Turdi S; Thomas DP; Zhou T; Ren J
    Toxicol Lett; 2010 Jun; 195(2-3):119-26. PubMed ID: 20303399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction.
    Williams AR; Hatzistergos KE; Addicott B; McCall F; Carvalho D; Suncion V; Morales AR; Da Silva J; Sussman MA; Heldman AW; Hare JM
    Circulation; 2013 Jan; 127(2):213-23. PubMed ID: 23224061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy.
    Memon IA; Sawa Y; Miyagawa S; Taketani S; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):646-53. PubMed ID: 16153908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte colony-stimulating factor treatment enhances the efficacy of cellular cardiomyoplasty with transplantation of embryonic stem cell-derived cardiomyocytes in infarcted myocardium.
    Cho SW; Gwak SJ; Kim IK; Cho MC; Hwang KK; Kwon JS; Choi CY; Yoo KJ; Kim BS
    Biochem Biophys Res Commun; 2006 Feb; 340(2):573-82. PubMed ID: 16376856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.
    Huang J; Zhang Z; Guo J; Ni A; Deb A; Zhang L; Mirotsou M; Pratt RE; Dzau VJ
    Circ Res; 2010 Jun; 106(11):1753-62. PubMed ID: 20378860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epac-Rap1-activated mesenchymal stem cells improve cardiac function in rat model of myocardial infarction.
    Khan I; Ali A; Akhter MA; Naeem N; Chotani MA; Iqbal H; Kabir N; Atiq M; Salim A
    Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 28039940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiomyogenic differentiation-independent improvement of cardiac function by human cardiomyocyte progenitor cell injection in ischaemic mouse hearts.
    den Haan MC; Grauss RW; Smits AM; Winter EM; van Tuyn J; Pijnappels DA; Steendijk P; Gittenberger-De Groot AC; van der Laarse A; Fibbe WE; de Vries AA; Schalij MJ; Doevendans PA; Goumans MJ; Atsma DE
    J Cell Mol Med; 2012 Jul; 16(7):1508-21. PubMed ID: 22003890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of interleukin-7 in fusion of rat bone marrow mesenchymal stem cells with cardiomyocytes in vitro and improvement of cardiac function in vivo.
    Haneef K; Ali A; Khan I; Naeem N; Jamall S; Salim A
    Cardiovasc Ther; 2018 Dec; 36(6):e12479. PubMed ID: 30451388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of cardiac function by placenta-derived mesenchymal stem cells does not require permanent engraftment and is independent of the insulin signaling pathway.
    Passipieri JA; Kasai-Brunswick TH; Suhett G; Martins AB; Brasil GV; Campos DB; Rocha NN; Ramos IP; Mello DB; Rodrigues DC; Christie BB; Silva-Mendes BJ; Balduíno A; Sá RM; Lopes LM; Goldenberg RC; Campos de Carvalho AC; Carvalho AB
    Stem Cell Res Ther; 2014 Aug; 5(4):102. PubMed ID: 25145631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium.
    Smits AM; van Laake LW; den Ouden K; Schreurs C; Szuhai K; van Echteld CJ; Mummery CL; Doevendans PA; Goumans MJ
    Cardiovasc Res; 2009 Aug; 83(3):527-35. PubMed ID: 19429921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined transplantation of skeletal myoblasts and bone marrow stem cells for myocardial repair in rats.
    Ott HC; Bonaros N; Marksteiner R; Wolf D; Margreiter E; Schachner T; Laufer G; Hering S
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):627-34. PubMed ID: 15037282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and bioenergetic modulations in the infarct border zone following autologous mesenchymal stem cell transplantation.
    Feygin J; Mansoor A; Eckman P; Swingen C; Zhang J
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1772-80. PubMed ID: 17573463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia.
    Roell W; Lewalter T; Sasse P; Tallini YN; Choi BR; Breitbach M; Doran R; Becher UM; Hwang SM; Bostani T; von Maltzahn J; Hofmann A; Reining S; Eiberger B; Gabris B; Pfeifer A; Welz A; Willecke K; Salama G; Schrickel JW; Kotlikoff MI; Fleischmann BK
    Nature; 2007 Dec; 450(7171):819-24. PubMed ID: 18064002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms.
    Santos Nascimento D; Mosqueira D; Sousa LM; Teixeira M; Filipe M; Resende TP; Araújo AF; Valente M; Almeida J; Martins JP; Santos JM; Bárcia RN; Cruz P; Cruz H; Pinto-do-Ó P
    Stem Cell Res Ther; 2014 Jan; 5(1):5. PubMed ID: 24411922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells from ischemic heart disease patients improve left ventricular function after acute myocardial infarction.
    Grauss RW; Winter EM; van Tuyn J; Pijnappels DA; Steijn RV; Hogers B; van der Geest RJ; de Vries AA; Steendijk P; van der Laarse A; Gittenberger-de Groot AC; Schalij MJ; Atsma DE
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2438-47. PubMed ID: 17644573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicles from human embryonic stem cell-derived cardiovascular progenitor cells promote cardiac infarct healing through reducing cardiomyocyte death and promoting angiogenesis.
    Wu Q; Wang J; Tan WLW; Jiang Y; Wang S; Li Q; Yu X; Tan J; Liu S; Zhang P; Tiang Z; Chen Z; Foo RS; Yang HT
    Cell Death Dis; 2020 May; 11(5):354. PubMed ID: 32393784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant Retrograde Coronary Venous Infusion of Basic Fibroblast Growth Factor Enhances Engraftment and Differentiation of Bone Marrow Mesenchymal Stem Cells for Cardiac Repair after Myocardial Infarction.
    Wang X; Zhen L; Miao H; Sun Q; Yang Y; Que B; Lopes Lao EP; Wu X; Ren H; Shi S; Lau WB; Ma X; Ma C; Nie S
    Theranostics; 2015; 5(9):995-1006. PubMed ID: 26155315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term tracking of bone marrow progenitor cells following intracoronary injection post-myocardial infarction in swine using MRI.
    Graham JJ; Foltz WD; Vaags AK; Ward MR; Yang Y; Connelly KA; Vijayaraghavan R; Detsky JS; Hough MR; Stewart DJ; Wright GA; Dick AJ
    Am J Physiol Heart Circ Physiol; 2010 Jul; 299(1):H125-33. PubMed ID: 20418483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.